Health care supply in patients with Ehlers-Danlos syndromes and generalized hypermobility spectrum disorder: a German perspective
Open Access
- 16 August 2025
- journal article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 20 (1) , 436
Abstract
Background: Diagnosing Ehlers-Danlos syndromes (EDS) and EDS-related “hypermobility spectrum disorder” (HSD) is challenging and cutaneous manifestations often serve as indicators of these rare connective tissue disorders. Only limited data exist on the healthcare of EDS/HSD in Germany as specialized services have been missing and a national register is not available. Objectives: In 2020, a dermatologic-orthopedic EDS outpatient service was initiated at the University Hospital of Cologne, Germany. The objectives of the present survey were to examine the “medical journey” and the disease burden of our patients. Methods: A pseudonymized paper survey was sent to all adults who were diagnosed with hypermobile EDS (hEDS), classical EDS (cEDS), classical-like EDS (clEDS) or generalized HSD at the EDS Cologne service from December 2021 until May 2023. Results: Of the 99 participants, 80 were diagnosed with hEDS/HSD, 16 with cEDS and 3 with clEDS. The mean time to diagnosis was 22.0 years (14.5 years for cEDS/clEDS vs. 23.0 years for hEDS/HSD). 24.2% of the participants had a recognized degree of disability of ≥ 50, the average sick leave in the last 3 months was 4.6 days for cEDS/clEDS and 21.3 days for hEDS/HSD. 44.9% of the hEDS/HSD patients reported on having at least four comorbidities compared to 21.1% in the cEDS/clEDS group (p = 0.023). At least 15 medical specialties were involved in the diagnostics and treatment of participants with multiple therapeutic modalities. Conclusions: This is the first study providing an insight on the healthcare supply of EDS/HSD patients in Germany. Participants in our survey had a much longer “diagnostic journey” than the one in previous studies and suffered from high morbidity despite high healthcare utilization. Our results point to the urgent necessity of a better coordinated, multidisciplinary care for patients with these complex genodermatoses including innovative political structures, further research and international networking.Keywords
Funding Information
- Universitätsklinikum Köln
This publication has 54 references indexed in Scilit:
- Shoulder function, pain and health related quality of life in adults with joint hypermobility syndrome/Ehlers–Danlos syndrome-hypermobility typeDisability and Rehabilitation, 2016
- Psychiatric disorders in Ehlers–Danlos syndrome are frequent, diverse and strongly associated with painRheumatology International, 2015
- Ehlers Danlos syndrome and gastrointestinal manifestations: a 20‐year experience at Mayo ClinicNeurogastroenterology & Motility, 2015
- Self-reported quality of life, anxiety and depression in individuals with Ehlers-Danlos syndrome (EDS): a questionnaire studyBMC Musculoskeletal Disorders, 2015
- Self‐reported utilization of mental health services in the adult German population – evidence for unmet needs? Results of the DEGS1‐Mental Health Module (DEGS1‐MH)International Journal of Methods in Psychiatric Research, 2014
- The relationship between benign joint hypermobility syndrome and psychological distress: a systematic review and meta-analysisRheumatology, 2013
- Multidisciplinary treatment of disability in ehlers–danlos syndrome hypermobility type/hypermobility syndrome: A pilot study using a combination of physical and cognitive‐behavioral therapy on 12 womenAmerican Journal of Medical Genetics Part A, 2013
- Medication, Surgery, and Physiotherapy Among Patients With the Hypermobility Type of Ehlers-Danlos SyndromeArchives of Physical Medicine and Rehabilitation, 2011
- Empowerment of patients: lessons from the rare diseases communityThe Lancet, 2008
- Ehlers‐Danlos syndrome – a historical reviewBritish Journal of Haematology, 2008